BL

Brendan Larder

VB Virco Bvba: 4 patents #1 of 14Top 8%
VN Virco N.V.: 3 patents #2 of 8Top 25%
GW Glaxo Wellcome: 2 patents #105 of 449Top 25%
BW Burroughs Wellcome: 1 patents #145 of 312Top 50%
SL Smithkline Beecham Limited: 1 patents #893 of 1,624Top 55%
📍 Sydenham, GB: #7 of 98 inventorsTop 8%
Overall (All Time): #385,493 of 4,157,543Top 10%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
8574831 Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance Pascale Dehertogh, Kurt Hertogs, Dechao Wang 2013-11-05
8563236 Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance Kurt Hertogs, Rudi Pauwels 2013-10-22
7494768 Mutational profiles in HIV-1 protease and reverse transcriptase correlated with phenotypic drug resistance Kurt Hertogs, Rudi Pauwels 2009-02-24
7292944 Establishment of biological cut-off values for predicting resistance to therapy Richard P. Harrigan, Kurt Hertogs 2007-11-06
7235387 Method for mutation detection in HIV-1 using pol sequencing Sharon Kemp, Stuart Bloor, Ann Brophy 2007-06-26
7206699 Methods for measuring therapy resistance Stuart Bloor, Kurt Hertogs, Pascale Dehertogh, Rudy Mortier 2007-04-17
RE39282 Nucleic acid derivatives Sharon Kemp 2006-09-12
7087375 Method for determining the mechanism of HIV RT inhibitors Johan Lennerstrand 2006-08-08
7058616 Method and system for predicting resistance of a disease to a therapeutic agent using a neural network Dechao Wang 2006-06-06
6800463 Method for mutation detection in HIV-1 using pol sequencing Sharon Kemp, Stuart Bloor, Ann Brophy 2004-10-05
RE37918 Nucleic acid derivatives Sharon D. Kemp nee Symons 2002-12-03
6177435 Therapeutic combinations Sharon Dawn Symons 2001-01-23
5409810 Nucelic acid derivatives Sharon Dawn Symons 1995-04-25